Valuation Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 07/07/2026			5-day change	1st Jan Change
2,742.00 ^MXN	+0.62%		0.00%	+9.68%

07-14	US FDA approves Celcuity's breast cancer drug	RE
07-14	Where would AI lead Pharma in the long run?

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	196,458	194,448	207,167	195,514	266,003	276,443	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	3.92%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	308,446	304,945	299,249
Change	-	-0.57%	7.71%	-2.61%	35.8%	6.41%	-1.13%	-1.87%
P/E	8.2x	28.3x	14.1x	16.5x	19.2x	21.2x	17.9x	15.5x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	6.32x	5.92x	5.31x
PEG	-	-0.4x	0x	-1x	0.9x	-29.42x	1x	1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	4.86x	4.58x	4.32x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.42x	5.06x	4.67x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	13.1x	12x	10.9x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	14.4x	13.1x	11.9x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	22.9x	18.8x	16.1x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	4.38%	5.32%	6.22%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.399	4.542	4.779
Rate of return	3.83%	3.87%	3.79%	3.94%	-	2.9%	3%	3.15%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.158	8.45	9.782
Distribution rate	31.4%	110%	53.5%	65.1%	-	61.5%	53.8%	48.9%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	56,908	60,310	64,022
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,491	25,337	27,507
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,482	23,258	25,213
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,079	15,643	17,519
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	32,003	28,502	22,806
Reference price ²	87.82	90.40	100.79	97.79	138.63	151.54	151.54	151.54
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,830,549	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	31/01/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.25x	12.25x	25.43x	0.59%	1,028B
JOHNSON & JOHNSON	27.09x	6.22x	16.9x	2.1%	611B
ABBVIE INC.	30.33x	7.27x	14.9x	2.81%	432B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	323B
ASTRAZENECA PLC	20.69x	4.37x	12.08x	2.02%	257B
NOVO NORDISK A/S	13.99x	5.26x	10.84x	3.55%	217B
AMGEN INC.	23.3x	6.19x	10.94x	2.84%	192B
GILEAD SCIENCES, INC.	-46.85x	5.61x	31x	2.5%	161B
PFIZER INC.	12.32x	3.04x	7.69x	7.12%	138B
Average	14.73x	6.06x	15.61x	2.95%	373.24B
Weighted average by Cap.	23.06x	7.65x	17.85x	2.18%